Off-hours Primary PCI Still Have the Highest Mortality Rate?

According to this contemporary study, in the current organized STEMI network, patients admitted to a tertiary high-volume center for primary PCI are managed similarly and have similar prognosis regardless admission time. 

¿Las angioplastias primarias a la madrugada siguen teniendo mayor mortalidad?

Several prior studies have shown primary PCI during off-hours (6 pm to 8 am) had worse outcomes vs. on-hour interventions (8 am to 6 pm). Something similar occurred when comparing weekend and holiday outcomes vs. working days. 

This study analyzed the outcomes of 2167 consecutive STEMI patients admitted to a tertiary primary PCI center 24 hours, 7 days a week, all year round.


Read also: Net Benefit of Left Atrial Appendage Closure vs. Anticoagulation in Atrial Fibrillation.


1048 patients (48.3%) were admitted on-hours and 1119 (51.7%) off-hours.

Baseline clinical characteristics were well balanced between the groups, including cardiac arrest rate (7.9% vs 8.8%) and cardiogenic shock (12.3% vs 14.7%).

Mean time between symptom onset and fist medical contact and mean time between first contact and sheath insertion resulted similar between both groups (120 min vs. 126 min; p=0.25 y 90 min vs. 93 min; p=0.58, respectively), same as radial access rate (85.6% vs. 87.5%; p=0.27).


Read also: International Consensus to Prevent Radial Artery Occlusion After Interventions.


There was no association between time and procedure and in-hospital mortality (8.1% vs. 7.0%; p=0.49) and mortality at one year (11.0% vs. 11.1%; p=0.89).

Conclusion

The contemporary organized STEMI network has successfully beaten the myth of worse off hours PCI prognosis. This was true for both in-hospital mortality and one year mortality, at least for one high volume tertiary center. 

Original title: On- Versus Off-Hours Presentation and Mortality of ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention.

Reference: Benoit Lattuca et al. J Am Coll Cardiol Intv 2019, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...